Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. announced that it has received $93,660,000 in funding led by CITIC Securities Company Limited and CITIC Med Funds. on June 4, 2021. The transaction included participation from Yingke Innovation Asset Management Co., Ltd., Hosencare Investment Management (Shanghai) Ltd., Beijing Lanpu Capital Management Co.,Ltd., Jolmo Investment Management Co., Ltd., and GP Capital Co., Ltd.